Standard versus prolonged intervals to surgery in resectable esophageal cancer: does timing matter?

Ann Oncol. 2023 Nov;34(11):960-961. doi: 10.1016/j.annonc.2023.09.3105. Epub 2023 Sep 19.

Authors

S Derks¹, H W M van Laarhoven²

Affiliations

¹ Amsterdam UMC location Free University, Medical Oncology, Amsterdam; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam; Oncode Institute, Utrecht. Electronic address: s.derks@amsterdamumc.nl.
² Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam; Amsterdam UMC location University of Amsterdam, Medical Oncology, Amsterdam, The Netherlands.

PMID: 37734663
DOI: 10.1016/j.annonc.2023.09.3105

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cisplatin
Esophageal Neoplasms* / surgery
Humans
Neoadjuvant Therapy

Substances

Cisplatin